<DOC>
	<DOCNO>NCT02900404</DOCNO>
	<brief_summary>This study shall determine whether XAPPORT - mobile device app base different guideline , summary product characteristic rivaroxaban , clinical fact practice - provide adequate guidance physician attend patient undergo elective surgery , interrupt treatment rivaroxaban surgery , decide approach pre- postoperative management anticoagulation .</brief_summary>
	<brief_title>Verification XAPPORT : Decision Support App Physicians Used Patients Anticoagulated With Rivaroxaban Terms Anticoagulation Management Elective Surgery : Verification Process Medical Decision Algorithm</brief_title>
	<detailed_description>Study design : `` retrospective/prospective '' Observational study</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Rivaroxaban</mesh_term>
	<criteria>Female male patient â‰¥18 year provide sign date informed consent use medical data Patient treat rivaroxaban surgery nonvalvular atrial fibrillation ( NVAF ) venous thromboembolism/pulmonary embolism ( VTE/PE ) Elective surgery department General Surgery Orthopedics / Trauma Surgery perform within last 12 month study start The patient discharge hospital Patient 's medical record available data entry Patient participate interventional drug study within 3 month prior surgery discharge hospital</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>